Biosynex SA Statistics
Biosynex SA (0DL) Stock Statistics & Valuation Metrics
Total Valuation
Biosynex SA has a market cap or net worth of EUR 15.10M. The enterprise value is EUR 70.41T.
- Market Cap
- EUR 15.10M
- Enterprise Value
- EUR 70.41T
Share Statistics
Biosynex SA has 18,748,032 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 18,748,032
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Biosynex SA’s return on equity (ROE) is -1.79 and return on invested capital (ROIC) is -4.09%.
- Return on Equity (ROE)
- -1.79
- Return on Assets (ROA)
- -0.43
- Return on Invested Capital (ROIC)
- -4.09%
- Return on Capital Employed (ROCE)
- -0.04
- Revenue Per Employee
- 239.80K
- Profits Per Employee
- -146.60K
- Employee Count
- 397
- Asset Turnover
- 0.70
- Inventory Turnover
- 4.32
Valuation Ratios
The current PE Ratio of Biosynex SA is -1.12. Biosynex SA’s PEG ratio is -0.01.
- PE Ratio
- -1.12
- PS Ratio
- 0.17
- PB Ratio
- 0.47
- Price to FCF
- -1.76
- Price to Operating Cash Flow
- -2.60
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Biosynex SA had revenue of 95.20M and earned -58.20M in profits. Earnings per share was -3.10.
- Revenue
- 95.20M
- Gross Profit
- -3.60M
- Operating Income
- -4.70M
- Pretax Income
- -59.30M
- Net Income
- -58.20M
- EBITDA
- 8.50M
- Earnings Per Share (EPS)
- -3.10
Cash Flow
In the last 12 months, operating cash flow was -5.89M and capital expenditures -2.69M, giving a free cash flow of -8.57M billion.
- Operating Cash Flow
- -5.89M
- Free Cash Flow
- -8.57M
- Free Cash Flow per Share
- -0.46
Dividends & Yields
Biosynex SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -56.87%
- Earnings Yield
- -89.98%
Stock Price Statistics
- Beta
- -0.32
- 52-Week Price Change
- 49.24%
- 50-Day Moving Average
- 0.84
- 200-Day Moving Average
- 0.88
- Relative Strength Index (RSI)
- 42.57
- Average Volume (3m)
- 1,193
Financial Position
Biosynex SA as a current ratio of 1.94, with Debt / Equity ratio of 190.01%
- Current Ratio
- 1.94
- Quick Ratio
- 1.14
- Debt to Market Cap
- 5.52
- Net Debt to EBITDA
- 6.26
- Interest Coverage Ratio
- -1.06
Taxes
In the past 12 months, Biosynex SA has paid -1.10M in taxes.
- Income Tax
- -1.10M
- Effective Tax Rate
- 0.02
Enterprise Valuation
Biosynex SA EV to EBITDA ratio is 11.51, with an EV/FCF ratio of -7.96.
- EV to Sales
- 0.76
- EV to EBITDA
- 11.51
- EV to Free Cash Flow
- -7.96
- EV to Operating Cash Flow
- -11.59
Balance Sheet
Biosynex SA has EUR 8.46M in cash and marketable securities with EUR 61.65M in debt, giving a net cash position of -EUR 53.19M billion.
- Cash & Marketable Securities
- EUR 8.46M
- Total Debt
- EUR 61.65M
- Net Cash
- -EUR 53.19M
- Net Cash Per Share
- -EUR 2.84
- Tangible Book Value Per Share
- -EUR 2.06
Margins
Gross margin is -4.89%, with operating margin of -6.11%, and net profit margin of -15.33%.
- Gross Margin
- -4.89%
- Operating Margin
- -6.11%
- Pretax Margin
- -14.67%
- Net Profit Margin
- -15.33%
- EBITDA Margin
- 6.59%
- EBIT Margin
- -7.81%
Analyst Forecast
The average price target for Biosynex SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -8.15%
- EPS Growth Forecast
- 82.87%
